Short interest in Ovid Therapeutics Inc (NASDAQ:OVID) increased during the last reporting period, rising from 606.85K to 679.89K. This put 1.16% of the company's publicly available shares short.

Short interest for Ovid Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Ovid Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 103.91K shares traded per day, it would take 6.54 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.